Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Emerald Health Therapeutics Inc EMHTF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.

OTCQB:EMHTF - Post Discussion

Emerald Health Therapeutics Inc > EMH Q1 results - Demonstrates Continued Growth in Sales
View:
Post by SweedInvestor on May 31, 2019 9:24am

EMH Q1 results - Demonstrates Continued Growth in Sales

https://www.investornetwork.com/news/N-2F870B0D6E053CFC435BA2AE6C1E90 This is great IMO. Stay long and GLTA!
Comment by Dundas16 on May 31, 2019 10:55am
I agree Sweed; Improved Sales Reduced Loss Continued Growth Definetly solid long! GLTA
Comment by goal111 on May 31, 2019 12:13pm
i believe upcoming quarters will have very strong numbers and will boost the momentum of share price. They are just starting to fill their po for Quebec, Alberta, Manitoba and PEI. SYNC 25 CBD oil will be a hit in the adult market and going generate alot of rev for the company. Lets hope soon they launch new product line with Natural Factors group and also bring Endo products in the Canadian ...more  
Emerald Health Therapeutics Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested